MI CARES: Club Drugs and Hallucinogens Module is organized by Michigan State University College of Osteopathic Medicine (MSUCOM).
Event Date: September 01, 2023
End Date: August 31, 2026
Topic:
Club drugs and hallucinogens - Cara Poland, MD; Mark Greenwald, Ph.D.; Kelly Strutz, Ph.D., MPH
Learning Objectives:
1. Describe epidemiologic features of club drugs and hallucinogens use disorders using national data sources, including prevalence, trends, corelates and risk factors.
2. Describe the pharmacokinetic properties and pharmacological actions of club drugs and hallucinogens.
3. Identify and differentiate the signs and symptoms associated with club drugs and hallucinogens intoxication and withdrawal.
4. Interpret the DSM-5 criteria for diagnosis of Club Drugs and Hallucinogens Use Disorder and severity of symptoms and recognize how this information applies to the continuum of care for patients.
5. Discuss prevention services that focus on helping patients make healthy choices or change harmful behaviors.
6. Evaluate the various ways in which policies, programs and interventions have been proven to reduce the harmful effects associated with club drugs and hallucinogens use disorders.
7. Recognize the various types of evidence-based screening tools, referral, and care management strategies.
Additional details will be posted as soon as information is available.
Accreditation Statement:
Michigan State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Michigan State University designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved